scholarly journals Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells

Oncotarget ◽  
2015 ◽  
Vol 6 (14) ◽  
pp. 12682-12696 ◽  
Author(s):  
Riesa M. Burnett ◽  
Kelly E. Craven ◽  
Purna Krishnamurthy ◽  
Chirayu P. Goswami ◽  
Sunil Badve ◽  
...  
PLoS Biology ◽  
2020 ◽  
Vol 18 (11) ◽  
pp. e3000872
Author(s):  
Yajing Lv ◽  
Xiaoshuang Wang ◽  
Xiaoyu Li ◽  
Guangwei Xu ◽  
Yuting Bai ◽  
...  

Metabolic reprogramming to fulfill the biosynthetic and bioenergetic demands of cancer cells has aroused great interest in recent years. However, metabolic reprogramming for cancer metastasis has not been well elucidated. Here, we screened a subpopulation of breast cancer cells with highly metastatic capacity to the lung in mice and investigated the metabolic alternations by analyzing the metabolome and the transcriptome, which were confirmed in breast cancer cells, mouse models, and patients’ tissues. The effects and the mechanisms of nucleotide de novo synthesis in cancer metastasis were further evaluated in vitro and in vivo. In our study, we report an increased nucleotide de novo synthesis as a key metabolic hallmark in metastatic breast cancer cells and revealed that enforced nucleotide de novo synthesis was enough to drive the metastasis of breast cancer cells. An increased key metabolite of de novo synthesis, guanosine-5'-triphosphate (GTP), is able to generate more cyclic guanosine monophosphate (cGMP) to activate cGMP-dependent protein kinases PKG and downstream MAPK pathway, resulting in the increased tumor cell stemness and metastasis. Blocking de novo synthesis by silencing phosphoribosylpyrophosphate synthetase 2 (PRPS2) can effectively decrease the stemness of breast cancer cells and reduce the lung metastasis. More interestingly, in breast cancer patients, the level of plasma uric acid (UA), a downstream metabolite of purine, is tightly correlated with patient’s survival. Our study uncovered that increased de novo synthesis is a metabolic hallmark of metastatic breast cancer cells and its metabolites can regulate the signaling pathway to promote the stemness and metastasis of breast cancer.


Heliyon ◽  
2021 ◽  
Vol 7 (2) ◽  
pp. e06252
Author(s):  
Wei Chen ◽  
Shihyun Park ◽  
Chrishma Patel ◽  
Yuxin Bai ◽  
Karim Henary ◽  
...  

2020 ◽  
Vol 107 ◽  
pp. 65-77 ◽  
Author(s):  
Akshay A. Narkhede ◽  
James H. Crenshaw ◽  
David K. Crossman ◽  
Lalita A. Shevde ◽  
Shreyas S. Rao

2016 ◽  
Vol 76 (18) ◽  
pp. 5209-5218 ◽  
Author(s):  
Shreyas S. Rao ◽  
Grace G. Bushnell ◽  
Samira M. Azarin ◽  
Graham Spicer ◽  
Brian A. Aguado ◽  
...  

2013 ◽  
Vol 8 ◽  
pp. 9 ◽  
Author(s):  
Kristine Raaby Jakobsen ◽  
Emilie Sørensen ◽  
Karin Kathrine Brøndum ◽  
Tina Fuglsang Daugaard ◽  
Rune Thomsen ◽  
...  

Gene ◽  
2021 ◽  
Vol 775 ◽  
pp. 145419
Author(s):  
Manish Tandon ◽  
Ahmad H. Othman ◽  
Marcus Winogradzki ◽  
Jitesh Pratap

Sign in / Sign up

Export Citation Format

Share Document